Host: Matt Birnholz, MD 

Guest: Everett E. Vokes, MD 


 To address some of the difficulties surrounding CT-based NSCLC screenings, Dr. Everett Vokes provides guidance to thwart false positives. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Host: Matt Birnholz, MD Guest: Everett E. Vokes, MD To address some of the difficulties surrounding CT-based NSCLC screenings, Dr. Everett Vokes provides guidance to thwart false positives. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facing False Positives in CT-Based NSCLC Screenings

According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.

Share Facing False Positives in CT-Based NSCLC Screenings

Sign up to save your podcasts

Facing False Positives in CT-Based NSCLC Screenings

Facing False Positives in CT-Based NSCLC Screenings